// App-Quantinova.ai

2489 : Therapeutic implication of identifying pancreatic cancer stem cells possessing fructose metabolic signature

Researchers

Presenter

  • Chia-Ning Shen

Principal Investigators

  • Chi-Che Hsieh

  • Wen-Shan Li

  • Michael Hsiao

Medical Centers

  • Academia Sinica - Genomics Research Ctr., Taipei, Taiwan

  • China Medical University - Ph.D.Program for Cancer Biology and Drug Discovery, Taichung, Taiwan

  • Academia Sinica - Institute of Chemistry, Taipei, Taiwan.

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Ophthalmology (OP)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Solid malignancies

  • Enhanced S cone syndrome

Biomarkers

  • ATP-binding cassette super-family G member 2

  • Cluster of Differentiation 44

  • Prominin 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A